Immunitybio Inc (NASDAQ:IBRX)
| 3.99 Delayed Data As of Jul 01 |  +0.27 / +7.26%Today’s Change | 2.60 Today|||52-Week Range 14.59 | -34.37% Year-to-Date |
Latest IBRX News | Press Releases
No recent news for Immunitybio Inc.
Today’s Trading
| Previous close | 3.72 |
| Today’s open | 3.70 |
| Day’s range | 3.70 - 4.06 |
| Volume | 60,100 |
| Average volume (3 months) | 1,800,388 |
| Market cap | $1.6B |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | +0.13% |
| Earnings growth (this year) | -1.12% |
| Earnings growth (next 5 years) | -47.93% |
| Revenue growth (last year) | +741.44% |
| P/E ratio | NM |
| Price/Sales | 2,533.77 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TVTXTravere Therapeutics... | +0.85 | +3.51% |
| AXSMAxsome Therapeutics ... | +2.35 | +6.14% |
| EBSEmergent BioSolution... | +0.75 | +2.42% |
| AUPHAurinia Pharmaceutic... | +1.33 | +13.23% |
Data as of 5:39pm ET, 07/01/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.23 |
| Annual revenue (last year) | $934.0K |
| Annual profit (last year) | -$346.8M |
| Net profit margin | -37,129.55% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
